Impact of TMPRSS6 Genetic Variants on Maternal Iron Status in Pregnancy: A Systematic Review
Birth Defects Research · 2025
DOI: 10.1002/bdr2.2538 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Birth Defects Research, 2025. Verfasst von Rezky Fauzan und 3 weiteren Autor:innen. Beteiligte Einrichtung: Doctoral Program in Biomedical Science, Faculty of Medicine, Universitas Andalas, Padang, Indonesia. Hauptthemen laut MEDLINE: Serine Endopeptidases, Iron, Membrane Proteins. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 42 Literaturangaben. Gefördert von: Ministry of Higher Education, Science, and Technology Indonesia.
Abstract (Originalsprache)
Objective
The TMPRSS6 gene encodes matriptase‐2, a serine protease that negatively regulates hepcidin and thus governs systemic iron homeostasis. Common polymorphisms have been implicated in altered iron indices in normal populations. To date, no systematic review has comprehensively assessed the impact of TMPRSS6 on maternal iron status and pregnancy outcomes. This review aims to elucidate the molecular mechanisms and clinical impact of TMPRSS6 variants on maternal iron status and obstetric complications.
Methods
A systematic review was conducted in accordance with PRISMA guidelines. English‐language articles published between 2015 and 2024 were retrieved from PubMed, Crossref, OpenAlex, and Google Scholar. Eligible studies assessed TMPRSS6 genotypes in relation to iron biomarkers and obstetric complications. Seven studies met inclusion criteria.
Results
Of 1243 articles identified, seven studies ( n = 1094 pregnant participants) met inclusion criteria. The rs855791 T‐allele and rs4820268 G‐allele consistently correlated with lower serum iron, reduced transferrin saturation, and elevated unsaturated iron‐binding capacity. These variants increased risks of iron‐deficiency anemia, gestational diabetes mellitus, and preeclampsia. Functional analyses indicated that altered matriptase‐2 activity leads to inappropriately high hepcidin, impaired dietary iron absorption, and downstream metabolic disturbances.
Conclusion
TMPRSS6 polymorphisms play a central role in disrupting iron regulation and contribute to obstetric complications. Incorporating TMPRSS6 genotyping into prenatal care may facilitate personalized risk stratification and optimized iron supplementation strategies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Doctoral Program in Biomedical Science, Faculty of Medicine, Universitas Andalas, Padang, Indonesia.
- Department of Obstetrics and Gynecology, Faculty of Medicine, Universitas Andalas, Padang, Indonesia.
- Department of Basic and Fundamental Nursing, Faculty of Nursing, Universitas Andalas, Padang, Indonesia.
- Department of Nutrition, Faculty of Medicine, Universitas Andalas, Padang, Indonesia.
ORCID-Profile: Nur Indrawaty Lipoeto
Förderung
- Ministry of Higher Education, Science, and Technology Indonesia
Zitieren
APA
Fauzan, R., Defrin, Susmiati, & Lipoeto, N. I. (2025). Impact of TMPRSS6 Genetic Variants on Maternal Iron Status in Pregnancy: A Systematic Review. Birth Defects Research. https://doi.org/10.1002/bdr2.2538
Vancouver
Fauzan R, Defrin, Susmiati, Lipoeto NI. Impact of TMPRSS6 Genetic Variants on Maternal Iron Status in Pregnancy: A Systematic Review. Birth Defects Research. 2025. doi:10.1002/bdr2.2538
BibTeX
@article{Fauzan2025,
author = {Fauzan, Rezky and Defrin and Susmiati and Lipoeto, Nur Indrawaty},
title = {Impact of TMPRSS6 Genetic Variants on Maternal Iron Status in Pregnancy: A Systematic Review},
journal = {Birth Defects Research},
year = {2025},
doi = {10.1002/bdr2.2538}
}
EUVIMED